Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries

Stroke Research and Treatment

Volumn 2017, Issue , 2017, Pages

  Ceornodolea, Andreea D ^a,b   Bal, Roland ^b   Severens, Johan L ^b  

^a EMbrace Institute   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; EUROPE; FRANCE; GENERAL PRACTITIONER; HUMAN; INCIDENCE; MEDICAL SPECIALIST; MORTALITY; NETHERLANDS; PREVALENCE; PREVENTIVE HEALTH SERVICE; REVIEW; ROMANIA; SCREENING; UNITED KINGDOM;

EID: 85021633836     PISSN: 20908105     EISSN: 20420056     Source Type: Journal    
DOI: 10.1155/2017/8593207     Document Type: Review

References (53)

1. J. A. Camm, P. Kirchhof, Y. H. G. Lip et al., "Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC)," Eur Heart J, vol. 31, no. 19, pp. 2369-2429, 2010.
2. P. Kirchhof, B. Ammentorp, H. Darius et al., "Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention of thromboemolic events-European registry in atrial fibrillation (PREFER in AF)," Europace, vol. 16, no. 1, pp. 6-14, 2014.
3. I. M. Ogilvie, N. Newton, S. A.Welner, W. Cowell, and G. Y. H. Lip, "Underuse of oral anticoagulants in atrial fibrillation: a systematic review," The American Journal of Medicine, vol. 123, no. 7, pp. 637-645, 2010.
4. C. Marini, F. De Santis, S. Sacco et al., "Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study," Stroke, vol. 36, no. 6, pp. 1115-1119, 2005.
5. P. Kakar, C. J. Boss, and G. Y. H. Lip, "Management of atrial fibrillation," Vasc Health Risk Manag, vol. 3, no. 1, pp. 109-116, 2007.
6. P. A.Wolf, R. D. Abbott, andW. B. Kannel, "Atrial fibrillation as an independent risk factor for stroke: the framingham study," Stroke, vol. 22, no. 8, pp. 983-988, 1991.
7. B. P. Krijthe, A. Kunst, E. J. Benjamin et al., "Projections on the number of individuals with atrial fibrillation in the European Union, from2000 to 2060," European Heart Journal, vol. 34, no. 35, pp. 2746-2751, 2013.
8. P. Kirchhof, G. Breithardt, J. Bax et al., "A roadmap to improve the quality of atrial fibrillation management," in Proceedings from the Fifth Atrial Fibrillation Network/European Heart Rhythm Association Consensus Conference, 2015.
9. G. Y. H. Lip, C. Laroche, M. I. Popescu et al., "Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF general pilot Registry," Europace, vol. 17, no. 12, pp. 1777-1786, 2015.
10. A. R.Kaba, J. A. Camm,M.T.Williams, andR. Sharma, "Managing atrial fibrillation in the global community: the European Perspective," Glob Carrdiol Sci Pract, vol. 24, no. 2, pp. 173-184, 2013.
11. G. Y. H. Lip, A. K. Gitt, J.-Y. Le Heuzey et al., "Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the rhythm-af study),"American Journal of Cardiology, vol. 113, no. 3, pp. 480-484, 2014.
12. R. Nieuwlaat, A. Capucci, A. J. Camm, S. B. Olsson, D. Andresen, Y. J. Le Heuzey et al., "Atrial fibrillation management: a prospective survey in ESC member countries the euro heart survey on atrial fibrillation," Eur Heart J, vol. 26, pp. 2422-2234, 2005.
13. H. E. Heemstra, R. Nieuwlaat, M. Meijboom, and H. J. Crijns, "The burden of atrial fibrillation in the Netherlands," Netherlands Heart Journal, vol. 19, no. 9, pp. 373-378, 2011.
14. T. N. Nguyen, S. N. Hilmer, and R. G. Cumming, "Review of epidemiology and management of atrial fibrillation in developing countries," International Journal of Cardiology, vol. 167, no. 6, pp. 2412-2420, 2013.
15. A. Malmivaara, A. Meretoja, M. Peltola et al., "Comparing ischaemic stroke in six European countries. The EuroHOPE register study," European Journal of Neurology, vol. 22, no. 2, pp. 284-291, 2015.
16. V. Fuster, L. E. Ryden, D. S. Cannom et al., "ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the american college of cardiology/american heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society," Circulation, vol. 114, pp. e257-e354, 2006.
17. J. Perk, G. De Backer, H. Gohlke et al., "The fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for cardiovascular prevention & amp," in Eur Heart J, vol. 33, p. 2126, 2012.
18. G. Y. H. Lip, C. M. Brechin, and D. A. Lane, "The global burden of atrial fibrillation and stroke: A systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe," Chest, vol. 142, no. 6, pp. 1489-1498, 2012.
19. Y. Zhang, A.-M. Chapman, M. Plested, D. Jackson, and F. Purroy, "The incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: A literature review," Stroke Research and Treatment, Article ID 436125, 2012.
20. T. Truelsen, B. Piechowski-Jóźwiak, R. Bonita, C. Mathers, J. Bogousslavsky, and G. Boysen, "Stroke incidence and prevalence in Europe: a review of available data," European Journal of Neurology, vol. 13, no. 6, pp. 581-598, 2006.
21. S. Fumagalli, R. Nieuwlaat, F. Tarantini et al., "management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation," Aging Clin Exp Res, vol. 24, no. 5, pp. 517-523, 2012.
22. G. Y. H. Lip, C. Laroche, G. Boriani et al., "Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational research programme atrial fibrillation (EORP-AF) pilot General Registry," Europace, vol. 17, no. 2, pp. 194-206, 2014.
23. K. Grosios, P. B. Gahan, and J. Burbidge, "Overview of healthcare in the UK," EPMA Journal, vol. 1, no. 4, pp. 529-534, 2010.
24. K. Chevreul, I. Durand-Zaleski, S. Bahrami, C. Hernandez-Quevedo, and P. F. Mladovsky, "Health system review," Health Syst Transit, vol. 12, no. 6, pp. 1-291, 2010.
25. S. Sandier, V. Paris, and D. Polton, "HiT summary France," Health Syst Transit, pp. 1-9, 2004.
26. S. Thomson, R. Osborn, D. Squires, and M. Jun, "International profiles of health care systems, 2013 Australia, Canada, Denmark, England, France, Germany, Italy, Japan, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United States," Commonwealth Fund, no. 1717, pp. 37-44, 2013.
27. W. Schafer, M. Kroneman, W. Boerma et al., "Health system review.WorldHealth Organization 2009, on behalf of the European Observatory on health systems and policies," vol. 12, no. 1, pp. 1-267, 2010.
28. OECD, "ealth at a glance," http://dx.doi.org/10.1787/health glance eur-2014-en.
29. R. C. Davis, F. D. R. Hobbs, J. E. Kenkre et al., "Prevalence of atrial fibrillation in the general population and in high-risk groups:The ECHOES study," Europace, vol. 14, no. 11, pp. 1553-1559, 2012.
30. A. Charlemagne, J. Blacher, A. Cohen et al., "Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data," Archives of Cardiovascular Diseases, vol. 104, no. 2, pp. 115-124, 2011.
31. S. Barra and S. Fynn, "Untreated atrial fibrillation in the United Kingdom: understanding the barriers and treatment options," Journal of the Saudi Heart Association, vol. 27, no. 1, pp. 31-43, 2015.
32. F.-E.Cotté, G.Chaize, I.Kachaner, A.-F. Gaudin, A.Vainchtock, and I. Durand-Zaleski, "Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France," Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 2, pp. e73-e83, 2014.
33. OECD, "Mortality from Heart Disease and Stroke," http://dx.doi.org/10.1787/health glance-2011-6-en.
34. NICE Clinical Guideline 180, "Atrial fibrillation: the management of atrial fibrillation NICE 2014," http://www.guidance.nice.org.uk/cg180.
35. NICE, "Atrial fibrillation: medicines to help reduce risk of stroke-what are the options? NICE 2014," http://guidance.nice.org.uk/CG180/PatientDecisionAid/pdf/English.
36. S. Lévy, M. Maarek, P. Coumel et al., "Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study," Circulation, vol. 99, no. 23, pp. 3028-3035, 1999.
37. E. Touzé, J.-P. Cambou, J. Ferrières et al., "Antithromboticmanagement after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies," Cerebrovascular Diseases, vol. 20, no. 2, pp. 78-84, 2005.
38. F. Purcarea and C. Usurelu, "Terapia antitrombotica revista societatii de medicina interna," vol. 1, 2009.
39. F. R. Rosendaal, F. J. M. Van der Meer, and S. C. Cannegieter, "Management of anticoagulant therapy: the Dutch experience," J ThrombThrombolysis, vol. 2, no. 4, pp. 265-269, 1996.
40. Federatie van Nederlandse Trombosediensten, http://www.fnt.nl/algemeen/jaarverslagen.html.
41. R.Willemsen, R. Pisters, H. Crijns, and B. deWit, "Implementatie van antitrombotische behandeling bij atriumfibrilleren," Huisarts En Wetenschap, vol. 54, no. 4, pp. 192-196, 2011.
42. J.-Y. Le Heuzey, B. Ammentorp, H. Darius et al., "Differences among western European countries in anticoagulation management of atrial fibrillation: data from the PREFER IN AF Registry," Thrombosis and Haemostasis, vol. 111, no. 5, pp. 833-841, 2014.
43. D. L. Arts, S. Visscher, W. Opstelten, J. C. Korevaar, A. Abu-Hanna, and H. C. P. M. vanWeert, "Frequency and risk factors for under-and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice," PLoS ONE, vol. 8, no. 7, Article ID e67806, 2013.
44. D. Zdrenghea, D. Pop, O. Penciu, and M. Zdrenghea, "Drug Treatment of Heart Failure in a General Romanian Hospital," Ro J internal med, vol. 47, no. 3, pp. 227-233, 2009.
45. E. Shantsila,A.Wolff, G. Y. H. Lip, andD.A. Lane, "Optimising stroke prevention in patients with atrial fibrillation: application of the grasp-af audit tool in a uk general practice cohort," British Journal of General Practice, vol. 65, no. 630, pp. e16-e23, 2015.
46. S. DeWilde, I. M. Carey, C. Emmas, N. Richards, and D. G. Cook, "Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care," Heart, vol. 92, no. 8, pp. 1064-1070, 2006.
47. F. D. R. Hobbs, D. A. Fitzmaurice, and S. Jowett, "The SAFE study-full report," Health Technol Assess 40, 2005.
48. NICE, "Atrial Fibrillation: the management of atrial fibrillation costing report implementing NICE Guidance in England.," http://www.nice.org.uk/guidance/cg36.
49. D. A. Fitzmaurice, F. D. R. Hobbs, S. Jowett et al., "Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial," British Medical Journal, vol. 335, no. 7616, pp. 383-386, 2007.
50. G. V. Naccarelli, H. Varker, J. Lin, and K. L. Schulman, "Increasing prevalence of atrial fibrillation and flutter in theUnited States,"American Journal of Cardiology, vol. 104, no. 11, pp. 1534-1539, 2009.
51. T.Wilke, A. Groth, S. Mueller et al., "Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients," Europace, vol. 15, no. 4, pp. 486-493, 2013.
52. C.Vladescu, G. Scîntee,V. Olsavszky, S. Allin, and P. Mladovsky, "Health system review," Health Syst Transit, vol. 10, no. 3, pp. 1-172, 2008.
53. D. L. Arts, A. G. Voncken, S.Medlock, A. Abu-Hanna, andH.C. P. M. vanWeert, "Reasons for intentional guideline non-adherence: A systematic review," International Journal of Medical Informatics, vol. 89, pp. 55-62, 2016.